Symbol="CFRX"
AssetType="Common Stock"
Name="ContraFect Corp"
Description="ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of protein and antibody therapeutics for the treatment of drug-resistant and life-threatening infectious diseases in the United States. The company is headquartered in Yonkers, New York."
CIK="1478069"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="28 WELLS AVENUE, 3RD FLOOR, YONKERS, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4110300"
EBITDA="-49612000"
PERatio="None"
PEGRatio="0"
BookValue="-2.003"
DividendPerShare="0"
DividendYield="0"
EPS="-868.07"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.812"
ReturnOnEquityTTM="-3.452"
RevenueTTM="0"
GrossProfitTTM="-1606434"
DilutedEPSTTM="-868.07"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.441"
EVToRevenue="-"
EVToEBITDA="0.163"
Beta="0.483"
num_52WeekHigh="27.44"
num_52WeekLow="0.9"
num_50DayMovingAverage="1.476"
num_200DayMovingAverage="5.31"
SharesOutstanding="3669900"
DividendDate="2020-02-04"
ExDividendDate="None"
symbol="CFRX"
open="1.11"
high="1.14"
low="1.09"
price="1.12"
volume="57636.00"
latest_trading_day="2023-07-28"
previous_close="1.11"
change="0.01"
change_percent="0.9009%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="66"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="34"
Volume_recent_avg="2671683"
Change_recent_avg="-0.04"
Delta_recent_avg="0.23"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-2.9"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_10"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="34"
Aroon_momentum_negative="66"
image_negative_thumbnail_id_1="108"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0068.jpeg"
image_negative_thumbnail_id_2="95"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_neutral_thumbnail_id_1="564"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_neutral_thumbnail_id_2="586"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_positive_thumbnail_id_1="964"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0126.jpeg"
image_positive_thumbnail_id_2="636"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0072.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
